Your browser doesn't support javascript.
loading
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Ramos, Rodrigo Nalio; Tosch, Caroline; Kotsias, Fiorella; Claudepierre, Marie-Christine; Schmitt, Doris; Remy-Ziller, Christelle; Hoffmann, Chantal; Ricordel, Marine; Nourtier, Virginie; Farine, Isabelle; Laruelle, Laurence; Hortelano, Julie; Spring-Giusti, Clementine; Sedlik, Christine; Le Tourneau, Christophe; Hoffmann, Caroline; Silvestre, Nathalie; Erbs, Philippe; Bendjama, Kaidre; Thioudellet, Christine; Quemeneur, Eric; Piaggio, Eliane; Rittner, Karola.
Afiliación
  • Ramos RN; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.
  • Tosch C; Present address: Laboratório de Investigação Médica em Patogênese e Terapia dirigida em Onco-Imuno-Hematologia Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo (HCFMUSP) São Paulo Brazil.
  • Kotsias F; Present address: Instituto D'Or de Ensino e Pesquisa São Paulo Brazil.
  • Claudepierre MC; Transgene SA Illkirch-Graffenstaden France.
  • Schmitt D; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.
  • Remy-Ziller C; Transgene SA Illkirch-Graffenstaden France.
  • Hoffmann C; Transgene SA Illkirch-Graffenstaden France.
  • Ricordel M; Transgene SA Illkirch-Graffenstaden France.
  • Nourtier V; Transgene SA Illkirch-Graffenstaden France.
  • Farine I; Transgene SA Illkirch-Graffenstaden France.
  • Laruelle L; Transgene SA Illkirch-Graffenstaden France.
  • Hortelano J; Transgene SA Illkirch-Graffenstaden France.
  • Spring-Giusti C; Transgene SA Illkirch-Graffenstaden France.
  • Sedlik C; Transgene SA Illkirch-Graffenstaden France.
  • Le Tourneau C; Transgene SA Illkirch-Graffenstaden France.
  • Hoffmann C; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.
  • Silvestre N; Department of Drug Development and Innovation (D3i) Institut Curie Paris and Saint-Cloud France.
  • Erbs P; Institut Curie INSERM U932, and Centre d'Investigation Clinique Biotherapie CICBT 1428 PSL Research University Paris France.
  • Bendjama K; Department of Surgical Oncology Institut Curie PSL Research University Paris France.
  • Thioudellet C; Transgene SA Illkirch-Graffenstaden France.
  • Quemeneur E; Transgene SA Illkirch-Graffenstaden France.
  • Piaggio E; Transgene SA Illkirch-Graffenstaden France.
  • Rittner K; Transgene SA Illkirch-Graffenstaden France.
Clin Transl Immunology ; 11(5): e1392, 2022.
Article en En | MEDLINE | ID: mdl-35573979

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Transl Immunology Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Transl Immunology Año: 2022 Tipo del documento: Article